Company profile for Adcendo

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Adcendo ApS is a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression. Adcendo has been part of BioInnovation Institute’s Creation House Program from mid 2019 unti...
Adcendo ApS is a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression. Adcendo has been part of BioInnovation Institute’s Creation House Program from mid 2019 until closing of series A financing in April 2021.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
BioInnovation Institute, Ole Maaløes Vej 3, Copenhagen, Capital Region of Den...
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/adcendo-aps-announces-fda-fast-track-designation-granted-to-adce-d01-for-the-treatment-of-soft-tissue-sarcoma-302578882.html

PR NEWSWIRE
09 Oct 2025

https://www.prnewswire.com/news-releases/adcendo-aps-announces-first-patient-dosed-in-phase-iii-adcelerate1-trial-of-adce-d01-302475071.html

PR NEWSWIRE
10 Jun 2025

https://www.prnewswire.com/news-releases/adcendo-aps-to-present-data-on-its-clinical-stage-adcs-adce-t02-and-adce-d01-at-the-2025-american-association-for-cancer-research-aacr-annual-meeting-302435250.html

PR NEWSWIRE
23 Apr 2025

https://www.prnewswire.com/news-releases/adcendo-aps-announces-changes-in-board-of-directors-and-strengthens-executive-leadership-team-302416200.html

PR NEWSWIRE
01 Apr 2025

https://www.prnewswire.com/news-releases/adcendo-aps-announces-us-fda-clearance-of-ind-application-for-phase-i-tiffany-01-trial-of-adce-t02-302384298.html

PR NEWSWIRE
26 Feb 2025
ADC biotech adds on $135M series B
ADC biotech adds on $135M series B

25 Nov 2024

// FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/novo-holdings-backed-adcendo-secures-135m-adc-pipeline

FIERCE BIOTECH
25 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty